Skip to content

Usage of a single dose of Tranexamic acid for reduction of blood loss in patients undergoing unilateral primary total knee replacement surgery

The efficacy of administration of a single dose tranexamic acid intravenously in the reduction of blood loss following a unilateral primary total knee replacement surgery - N/A

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/10/058283
Enrollment
100
Registered
2023-10-04
Start date
Unknown
Completion date
Unknown
Last updated
2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M179- Osteoarthritis of knee, unspecified

Interventions

Intervention1: Tranexamic Acid : Injection Tranexamic Acid 20mg/kg in 100ml 0.9% Normal saline, single dose by intravenous route after the administration of spinal anesthesia, 15 minutes before tourni

Sponsors

Sriman Narayan M
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients undergoing Unilateral Total Knee Replacement. 2. Both sexes. 3. Patients with Hemoglobin levels equal to more than 11g/dL. 4. Coagulation profile within normal limits.

Exclusion criteria

Exclusion criteria: 1. Patients undergoing simultaneous bilateral Total Knee Replacement Surgery. 2. Patient undergoing revision Knee Replacement surgeries. 3. Known patients of bleeding disorders. 4. Patients with known cases of Deep Vein Thrombosis, Pulmonary Embolism, and other vessel wall disorders. 5. Known cases of hematological disorders. 6. Known cases of renal insufficiency. 7. Patients with a Wells Score 2 or more. 8. Patients with a previous history of Cerebrovascular accidents, Transient Ischemic Attack, or Myocardial infarction. 9. Patient with a known history of seizure disorder. 10.Patients with known or suspected allergy to medication

Design outcomes

Primary

MeasureTime frame
Blood loss, measured by drain output, drop in Hemoglobin, and Packed Cell Volume. Intraoperatively, by the number of swabs and gauze soaked, field loss, and irrigation aspirator volume.Timepoint: Blood loss, measured by drain output at 24 hours and 48 hours postoperatively, drop in Hemoglobin and Packed Cell Volume on postoperative day 1 and postoperative day 5.

Secondary

MeasureTime frame
Requirement of blood transfusionTimepoint: Intraoperatively during the time of surgery, on postoperative day 1, on postoperative day 5.

Countries

India

Contacts

Public ContactSRIMAN NARAYAN M

Sri Ramachandra Institute of Higher Education and Research

mmohankumar69@hotmail.com8056275991

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026